CYN vs LIDR vs RBOT

For growth investors, AEye, Inc.

(LIDR) is the stronger pick with 15. 3% revenue growth year-over-year, versus -40. 5% for Cyngn Inc. (CYN). Analysts rate AEye, Inc. (LIDR) a "Hold" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, AEye, Inc.

(LIDR) delivered a total return of -99. 5%, compared to -100. 0% for Cyngn Inc. (CYN). Over 10 years, the gap is even starker: LIDR returned -99. 5% versus CYN's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cyngn Inc.

(CYN) is the lower-risk stock at 2. 18β versus AEye, Inc. 's 2. 51β — meaning LIDR is approximately 15% more volatile than CYN relative to the S&P 500. On balance sheet safety, AEye, Inc. (LIDR) carries a lower debt/equity ratio of 0% versus 79% for Vicarious Surgical Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), AEye, Inc.

(LIDR) is pulling ahead at 15. 3% versus -40. 5% for Cyngn Inc. (CYN). On earnings-per-share growth, the picture is similar: AEye, Inc. grew EPS 79. 9% year-over-year, compared to 21. 2% for Vicarious Surgical Inc.. Over a 3-year CAGR, CYN leads at -5. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Vicarious Surgical Inc.

(RBOT) is the more profitable company, earning 0. 0% net margin versus -145. 7% for AEye, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RBOT leads at 0. 0% versus -136. 2% for LIDR. At the gross margin level — before operating expenses — CYN leads at 38. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, AEye, Inc.

(LIDR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Cyngn Inc. (CYN) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIDR: -99. 5%, CYN: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CYN (Technology) and LIDR (Consumer Cyclical) and RBOT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CYN is a small-cap quality compounder stock; LIDR is a small-cap high-growth stock; RBOT is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.